ATE427731T1 - Biologisch absorbierbare fullstoffe bestehend aus phospholipidliposomen und hyaluronsaure und/oder derivaten davon - Google Patents

Biologisch absorbierbare fullstoffe bestehend aus phospholipidliposomen und hyaluronsaure und/oder derivaten davon

Info

Publication number
ATE427731T1
ATE427731T1 AT06724596T AT06724596T ATE427731T1 AT E427731 T1 ATE427731 T1 AT E427731T1 AT 06724596 T AT06724596 T AT 06724596T AT 06724596 T AT06724596 T AT 06724596T AT E427731 T1 ATE427731 T1 AT E427731T1
Authority
AT
Austria
Prior art keywords
derivatives
hyaluronic acid
liposomes
phospholipide
biologically absorbable
Prior art date
Application number
AT06724596T
Other languages
English (en)
Inventor
Lanfranco Callegaro
Devis Galesso
Anna Taglienti
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Application granted granted Critical
Publication of ATE427731T1 publication Critical patent/ATE427731T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT06724596T 2005-05-20 2006-04-21 Biologisch absorbierbare fullstoffe bestehend aus phospholipidliposomen und hyaluronsaure und/oder derivaten davon ATE427731T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000146A ITPD20050146A1 (it) 2005-05-20 2005-05-20 Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati

Publications (1)

Publication Number Publication Date
ATE427731T1 true ATE427731T1 (de) 2009-04-15

Family

ID=36734338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724596T ATE427731T1 (de) 2005-05-20 2006-04-21 Biologisch absorbierbare fullstoffe bestehend aus phospholipidliposomen und hyaluronsaure und/oder derivaten davon

Country Status (12)

Country Link
US (1) US8263118B2 (de)
EP (1) EP1888013B1 (de)
JP (1) JP2008540588A (de)
AT (1) ATE427731T1 (de)
AU (1) AU2006246751B2 (de)
CA (1) CA2608811C (de)
DE (1) DE602006006177D1 (de)
ES (1) ES2325420T3 (de)
IT (1) ITPD20050146A1 (de)
PL (1) PL1888013T3 (de)
RU (1) RU2394552C2 (de)
WO (1) WO2006122638A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742623A (zh) * 2005-07-13 2006-03-08 凌沛学 透明质酸磷脂复合物及其制备方法
ES2661728T3 (es) * 2005-10-03 2018-04-03 Pinksky, Mark A. Composiciones y métodos para el cuidado mejorado de la piel
JP2008133195A (ja) * 2006-11-27 2008-06-12 Konica Minolta Holdings Inc 水溶性薬剤内包リポソーム及びその製造方法
ITMI20072348A1 (it) 2007-12-17 2009-06-18 Medichem Srl Metodo per la rigenerazione cellulare di acido ialuronico e relativa composizione cosmetica
BE1018697A3 (fr) * 2009-03-16 2011-07-05 Auriga Internat Composition cosmetique a application topique comprenant de l'acide hyaluronique.
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
BR112012032153A2 (pt) * 2010-06-17 2017-08-08 Yeda Res And Development Company Ltd método para a lubrificação de uma ou mais superfícies não biológicas, método para a lubrificação de uma ou mais superfícies de um tecido biológico em um indivíduo mamífero, uso de lipossomas na fase em gel e lipossoma misto
RU2473352C2 (ru) 2011-04-21 2013-01-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Состав, имитирующий внутрисуставную жидкость, и способ получения добавки к ней
CN102489193B (zh) * 2011-11-28 2014-06-18 上海景峰制药有限公司 一种玻璃酸钠配液过程的溶解方法
MY186106A (en) * 2012-10-11 2021-06-22 Ascendis Pharma As Diagnosis, prevention and treatment of diseases of the joint
US10413491B2 (en) 2014-04-02 2019-09-17 Merz Pharma Gmbh & Co. Kgaa In vivo accelerated degradation of polysaccharide-containing fillers
EP3154413B1 (de) 2014-06-15 2021-08-25 Yeda Research and Development Co. Ltd. Oberflächenbehandlung von kontaktlinsen und behandlung von augenbeschwerden durch wasserlösliche polymere und lipide/liposomen
CN106176632B (zh) * 2016-08-16 2019-09-03 海南合瑞制药股份有限公司 一种注射用甲泼尼龙琥珀酸钠组合物
ES2754476B2 (es) 2018-10-15 2020-09-14 Consejo Superior Investigacion Gel lipidico nanoestructurado, procedimiento de preparacion y uso

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713747D0 (en) * 1987-06-12 1987-07-15 Unilever Plc Skin treatment composition
DE4322158C2 (de) * 1993-07-03 1997-04-10 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung sowie Verwendung einer derartigen Zusammensetzung
PT789584E (pt) 1994-11-04 2002-03-28 Polymun Scient Immunbio Forsch Aplicacao de superoxido-dismutase (sod) em liposomas
AU1101501A (en) 1999-10-27 2001-05-08 K-Quay Enterprises, Llc Methods and compositions for treatment of keratoconus using protease inhibitors
DE60012866T2 (de) * 1999-12-14 2005-09-08 Kibun Food Chemifa Co., Ltd. Propylenglykolhyaluronat und äusserlich anzuwendendes Hautpflegemittel, das dieses enthält
US20050123593A1 (en) * 2001-06-25 2005-06-09 Jonathan Thompson Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
CN100482546C (zh) * 2002-06-20 2009-04-29 株式会社吉野工业所 袋状吹塑成型容器
KR20050059003A (ko) * 2002-07-02 2005-06-17 프로사이트 코포레이션 펩티드 구리 착화합물 및 연조직 충전제를 함유하는조성물
CN1255671C (zh) * 2002-08-02 2006-05-10 上海数康生物科技有限公司 多标志物生物芯片信号分析方法
US20080010413A1 (en) 2006-07-07 2008-01-10 Krishnan Kunjunny Kailas Method and apparatus for application-specific dynamic cache placement

Also Published As

Publication number Publication date
DE602006006177D1 (de) 2009-05-20
AU2006246751A1 (en) 2006-11-23
ITPD20050146A1 (it) 2006-11-21
EP1888013A1 (de) 2008-02-20
WO2006122638A1 (en) 2006-11-23
EP1888013B1 (de) 2009-04-08
JP2008540588A (ja) 2008-11-20
PL1888013T3 (pl) 2009-09-30
US20120148667A1 (en) 2012-06-14
US8263118B2 (en) 2012-09-11
CA2608811A1 (en) 2006-11-23
AU2006246751B2 (en) 2010-08-19
RU2007141864A (ru) 2009-06-27
RU2394552C2 (ru) 2010-07-20
ES2325420T3 (es) 2009-09-03
CA2608811C (en) 2013-11-26

Similar Documents

Publication Publication Date Title
ATE427731T1 (de) Biologisch absorbierbare fullstoffe bestehend aus phospholipidliposomen und hyaluronsaure und/oder derivaten davon
CY1121134T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συγκολλησης
CY1118821T1 (el) Γελες με βαση υαλουρονικο οξυ οι οποιες περιλαμβανουν αναισθητικους παραγοντες
CY1120807T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
CY1117424T1 (el) Βενζοδιαζεπινικος αναστολεας bromodomain
CY1112653T1 (el) Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
BRPI0607009A2 (pt) stent endoureteral absorvìvel composto reforçada com fibra
DE102009035301A8 (de) Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung
AU2016204344A1 (en) Improved methods and compositions for wound healing
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
BRPI0508403A (pt) produtos de pelìcula tendo propriedades de desintegração controlada
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
DE602007014186D1 (de) Triazin-11-beta-hydroxysteroid-dehydrogenase-artige hemmer
BRPI0810390A2 (pt) Película, composição, e, métodos para administrar um material ativo, para melhorar a estabilidade de uma película e para manter a saúde sistêmica de um mamífero
EA201001639A1 (ru) Композиции и способы их получения и применения
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
PT2153260T (pt) Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma
BRPI0510336A (pt) monofilamento e método de utilização do mesmo e malha para hérnia e respectivo método de preparação
BRPI0510515A (pt) compostos de morfolina
DE602005015862D1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
BR112014007675A2 (pt) tratamento de doença articular degenerativa
TW200716628A (en) Novel compounds
EP2097115A4 (de) Verwendung von tropoelastin zur reparatur oder wiederherstellung von gewebe
EA201100872A1 (ru) Производные хиназолинамида
EA201170209A1 (ru) Производные пиперазина, применяемые в качестве модуляторов кальциевого канала ca2.2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1888013

Country of ref document: EP